Patents/Inventors

Xavier Duportet

ParisFR13 patents

15 Patents

US122140222025
Sequence-specific Antimicrobials by Blocking DNA Repair
ELIGO BIOSCIENCE
0 cites
US122140702025
Cosmetic Use of Engineered Postbiotics Comprising Bacteriocins And/or Endolysins
Eligo Bioscience
0 cites
US120983722024
Microbiome Modulation of a Host by Delivery of DNA Payloads with Minimized Spread
Eligo Bioscience
0 cites
US119707162024
Transcriptional Control in Prokaryotic Cells Using Dna-binding Repressors
ELIGO BIOSCIENCE
0 cites
US119525942024
Pharmaceutical Compositions Comprising Bacterial Delivery Vehicles and Uses Thereof
ELIGO BIOSCIENCE
0 cites
US119460562024
Optimized Vector for Delivery in Microbial Populations
INSTITUT PASTEUR
0 cites
US119055162024
Optimized Vector for Delivery in Microbial Populations
INSTITUT PASTEUR
0 cites
US118396452023
Therapeutic Use of Engineered Postbiotics Comprising Bacteriocins And/or Endolysins
Eligo Bioscience
0 cites
US117463522023
Microbiome Modulation of a Host by Delivery of DNA Payloads with Minimized Spread
Eligo Bioscience
0 cites
US116908802023
Modulation of Microbiota Function by Gene Therapy of the Microbiome to Prevent, Treat or Cure Microbiome-associated Diseases or Disorders
Eligo Bioscience
0 cites
US116333482023
Cosmetic Use of Engineered Postbiotics Comprising Bacteriocins And/or Endolysins
Eligo Bioscience
0 cites
US116177732023
Elimination of Colonic Bacterial Driving Lethal Inflammatory Cardiomyopathy
Kantonsspital St.gallen
0 cites
US115847812023
Chimeric Receptor Binding Proteins Resistant to Proteolytic Degradation
ELIGO BIOSCIENCE
0 cites
US115849182023
Transcriptional Control in Prokaryotic Cells Using Dna-binding Repressors
ELIGO BIOSCIENCE
0 cites
US115411062023
Method for Killing Bacteria with an Engineered Postbiotic
Eligo Bioscience
0 cites